Role of nav-anna as a causative factor for Prediabetes.
Phase 2
- Conditions
- Health Condition 1: R739- Hyperglycemia, unspecifiedHealth Condition 2: E889- Metabolic disorder, unspecifiedHealth Condition 3: E889- Metabolic disorder, unspecified
- Registration Number
- CTRI/2022/04/041618
- Lead Sponsor
- ational institute of Ayurveda jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
(1)-Patients who are fulfilling the conditions of Prediabetes according to who.
(2)-HbA1c between 42-47 mmol/mol.
(3)-Fasting blood sugar 100-126 mg/dl.
(4)-Post prandial blood sugar 140-180 mg/dl.
Exclusion Criteria
(1) Patients having diabetes Mellitus type 1,type 2 and other malignant disorders.
Pregnant women.
(2)Patients with history of critical (3)cardiovascular disease.
(4)Patients with major complications and in requirement of emergency treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Fasting Blood Sugar <br/ ><br>(2) hba1cTimepoint: (1) At the time of enrollment <br/ ><br>(2) After 3 months.
- Secondary Outcome Measures
Name Time Method To observe the level of impact of nav-anna (godhuma) in <br/ ><br>FBS altering in survey. <br/ ><br>Timepoint: Retrospectively. <br/ ><br>